, , p.0
Effect of a high concentration of fenofibrate (450 µM) on HepaRG cells. Data were obtained with 18 replicates. Amino acids, energy metabolites were quantified using the 12 C/ 13 C ratio. Concentrations were obtained in nM using an external calibration. Relative abundance was obtained using only 12 C/ 13 C ratios for polar metabolites and ratio with their corresponding unlabeled internal standard for lipids. Bars represent mean ± SD (n = 5). t-tests were performed for each metabolite, Figure S3 ,
, , p.0
isoleucine (Ile), serine (Ser), threonine (Thr), tryptophan (Trp), phenylalanine (Phe), arginine (Arg), histidine (his), asparagine (Asn), lysine (Lys), methionine (Met), proline (Pro), tyrosine (Tyr), valine (Val), 2,3-bisphosphoglycerate (2_3PG), 6_phosphogluconate (6-PG), a-ketoglutarate (a-KG), adenosine 5 -monophosphate (AMP), cytidine diphosphate (CDP), cytidine 5 -monophosphate (CMP), N-acetylglucosamine-1-phosphate (GlucNac-1P), N-acetylglucosamine-6-phosphate (GlucNac-6P), fructose-6-phosphate (Fru6P), fructose-1-phosphate (Fru1P), fructose bisphosphate (FruBP) guanosine diphosphate (GDP), guanosine diphosphate mannose (GDP-Man), glucose-6-phosphate (Glc6P), Triglycerides (TG), ceramides (Cer), phosphatidylcholines (PC), phosphatidylethanolamines (PE), sphingomyelins (SM), phosphatidylinositols (PI), alanine (Ala), aspartate (Asp), glutamine (Gln), glutamate (Glu), glycine (Gly), leucine (Leu) ,
, phosphoenolpyruvate (PEP), uridine diphosphate (UDP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), cytidine triphosphate (CTP), phosphoserine (P-Ser), sedoheptulose-7-phosphate (sed-7P), uridine diphosphate acetylglucosamine (UDP-AcGlcN), uridine diphosphate glucose (UDP-Glc), uridine 5 -monophosphate (UMP), mannose-6-phosphate (Man6P), pyridoxal-5-phosphate (P5P)
Metabolomics: The final frontier, Genome Med, 2012. ,
Systems metabolomics: From metabolomic snapshots to design principles, Curr. Opin. Biotechnol, vol.2020, pp.190-199 ,
Metabolomics: The apogee of the omics trilogy, Nat. Rev. Mol. Cell Biol, vol.13, pp.263-269, 2012. ,
Metabolomics-based methods for early disease diagnostics, Expert Rev. Mol. Diagn, vol.8, pp.617-633, 2008. ,
, Metabolomics in toxicology and preclinical research, vol.30, pp.209-225, 2013.
An untargeted metabolomics approach to investigate the metabolic modulations of HepG2 cells exposed to low doses of bisphenol A and 17?-estradiol, Front. Endocrinol, vol.9, 2018. ,
Arterio-venous metabolomics exploration reveals major changes across liver and intestine in the obese Yucatan minipig, Sci. Rep, vol.9, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02282295
metabolomics for plant improvement: Status and prospects. Front, Plant Sci, 1032. ,
Measuring the metabolome: Current analytical technologies, Analyst, vol.130, pp.606-625, 2005. ,
Improving metabolome coverage and data quality: Advancing metabolomics and lipidomics for biomarker discovery, Chem. Commun, vol.54, pp.6728-6749, 2018. ,
New plasma preparation approach to enrich metabolome coverage in untargeted metabolomics: Plasma protein bound hydrophobic metabolite release with proteinase K, Sci. Rep, vol.8, p.9541, 2018. ,
Global metabolomic and lipidomic analysis reveal the synergistic effect of bufalin in combination with cinobufagin against HepG2 Cells, J. Proteome Res, vol.19, pp.873-883, 2020. ,
Metabolomic and lipidomic profile in men with obstructive sleep apnoea: Implications for diagnosis and biomarkers of cardiovascular risk, Sci. Rep, vol.8, pp.1-12, 2018. ,
Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer, J. Pharm. Biomed. Anal, vol.180, 2020. ,
Metabolite profiling in plasma and tissues of ob/ob and db/db mice identifies novel markers of obesity and type 2 diabetes, Diabetologia, vol.58, pp.2133-2143, 2015. ,
Integration of metabolomics, lipidomics and clinical data using a machine learning method, BMC Bioinform, vol.17, pp.440-449, 2016. ,
MPLEx: A robust and universal protocol for single-sample integrative proteomic, metabolomic, and lipidomic analyses. mSystems, vol.1, pp.43-59, 2016. ,
A novel approach to the simultaneous extraction and non-targeted analysis of the small molecules metabolome and lipidome using 96-well solid phase extraction plates with column-switching technology, J. Chromatogr. A, pp.277-281, 1409. ,
In-vial dual extraction liquid chromatography coupled to mass spectrometry applied to streptozotocin-treated diabetic rats. Tips and pitfalls of the method, J. Chromatogr. A, pp.52-60, 1304. ,
In-vial dual extraction for direct Lc-ms analysis of plasma for comprehensive and highly reproducible metabolic fingerprinting, Anal. Chem, vol.84, pp.5992-5999, 2012. ,
Simultaneous extraction of metabolome and lipidome with methyl tert-butyl ether from a single small tissue sample for ultra-high performance liquid chromatography/mass spectrometry, J. Chromatogr. A, vol.1298, pp.9-16, 2013. ,
Validated comprehensive metabolomics and lipidomics analysis of colon tissue and cell lines, Anal. Chim. Acta, vol.1066, pp.79-92, 2019. ,
, Targeted metabolomics. Curr. Protoc. Mol. Boil, 1924.
Simultaneous metabolite, protein, lipid extraction (SIMPLEX): A combinatorial multimolecular omics approach for systems Biology, Mol. Cell. Proteom, vol.15, pp.1453-1466, 2016. ,
The power of LC-MS based multiomics: Exploring adipogenic differentiation of human mesenchymal stem/stromal cells, Molecules, vol.24, 2019. ,
The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses, Am. J. Respir. Crit. Care Med, vol.184, pp.647-655, 2011. ,
Simultaneous measurement of metabolite concentration and isotope incorporation by mass spectrometry, Anal. Chem, vol.92, pp.5890-5896, 2020. ,
URL : https://hal.archives-ouvertes.fr/hal-02563842
Quantitative analysis of the microbial metabolome by isotope dilution mass spectrometry using uniformly 13 C-labeled cell extracts as internal standards, Anal. Biochem, vol.336, pp.164-171, 2005. ,
Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach, Nat. Protoc, vol.3, pp.1299-1311, 2008. ,
Sampling of intracellular metabolites for stationary and non-stationary 13 C metabolic flux analysis in Escherichia coli, Anal. Biochem, vol.465, pp.38-49, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01268941
Development, characterization and comparisons of targeted and non-targeted metabolomics methods, PLoS ONE, vol.13, 2018. ,
Ellero-Simatos, S. Important considerations for sample collection in metabolomics studies with a special focus on applications to liver functions, vol.10, 2020. ,
Analysis of intracellular metabolites from microorganisms: Quenching and extraction protocols, vol.7, p.53, 2017. ,
Fast sampling method for mammalian cell metabolic analyses using liquid chromatography-mass spectrometry, Nat. Protoc, vol.10, pp.1-11, 2014. ,
Metabolite extraction from suspension-cultured mammalian cells for global metabolite profiling, Nat. Protoc, vol.6, pp.1241-1249, 2011. ,
Mammalian cell metabolomics: Experimental design and sample preparation, Electrophoresis, vol.34, pp.2762-2775, 2013. ,
Global metabolite analysis of yeast: Evaluation of sample preparation methods, Yeast, vol.22, pp.1155-1169, 2005. ,
Nonlinear partial differential equations and applications: Infection of a human hepatoma cell line by hepatitis B virus, Proc. Natl. Acad. Sci, vol.99, pp.15655-15660, 2002. ,
The GOLIATH project: Towards an internationally harmonised approach for testing metabolism disrupting compounds, Int. J. Mol. Sci, vol.2020 ,
URL : https://hal.archives-ouvertes.fr/hal-02638423
Intersection of toxicogenomics and high throughput screening in the Tox21 program: An NIEHS perspective, Int. J. Biotechnol, vol.14, pp.7-27, 2015. ,
Chapter 6-Separation methods, Fundamentals of Forensic Science, pp.121-151, 2015. ,
Extraction of organic compounds with room temperature ionic liquids, J. Chromatogr. A, pp.2268-2286, 2010. ,
Chapter 7-Drugs involved in drug-facilitated crimes (DFC): Analytical aspects: 1-Blood and urine, Toxicological Aspects of Drug-Facilitated Crimes ,
, , pp.159-180, 2014.
Acidic acetonitrile for cellular metabolome extraction from Escherichia coli, Anal. Chem, vol.79, pp.6167-6173, 2007. ,
Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies ,
, Genome Med, vol.4, p.33, 2012.
The metabolome of induced pluripotent stem cells reveals metabolic changes occurring in somatic cell reprogramming, Cell Res, vol.22, pp.168-177, 2011. ,
Multi-platform characterization of the human cerebrospinal fluid metabolome: A comprehensive and quantitative update ,
, Genome Med, 2012.
Fenofibrate-induced hepatotoxicity: A case with a special feature that is different from those in the LiverTox database, J. Clin. Pharm. Ther, vol.45, pp.204-207, 2019. ,
Opposite metabolic response to fenofibrate treatment in pregnant and virgin rats, J. Lipid Res, vol.43, pp.74-81, 2002. ,
Comparative transcriptomic and metabolomic analysis of fenofibrate and fish oil treatments in mice, Physiol. Genom, vol.43, pp.1307-1318, 2011. ,
The PPAR?-Humanized Mouse: A model to investigate species differences in liver toxicity mediated by Ppar?, Toxicol. Sci, vol.101, pp.132-139, 2007. ,
Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?, Diabetes Metab, vol.44, pp.143-149, 2018. ,
Mechanism of action of fibrates, Postgrad. Med J, vol.69, pp.34-41, 1993. ,
Peroxisome proliferator-activated receptor ? activation induces hepatic steatosis, suggesting an adverse effect, PLoS ONE, vol.9, 2014. ,
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells, Toxicol. Appl. Pharmacol, vol.276, pp.73-81, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01020611
Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver shionogi mice with hereditary fatty liver, Liver Int, vol.26, pp.613-620, 2006. ,
Hypolipidaemic effects of fenofibrate are not altered by mildronate-mediated normalization of carnitine concentration in rat liver, Biochimie, vol.80, pp.943-948, 1998. ,
Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens, Toxicol. Appl. Pharmacol, vol.398, 2020. ,
Fenofibrate simultaneously induces hepatic fatty acid oxidation, synthesis, and elongation in mice, J. Biol. Chem, vol.284, pp.34036-34044, 2009. ,
Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in fischer 344 male rats, Toxicol. Pathol, vol.37, pp.521-535, 2009. ,
Comparison of pharmacokinetics of two fenofibrate tablet formulations in healthy human subjects, Clin. Ther, vol.36, pp.967-973, 2014. ,
Metabolism disrupting chemicals and metabolic disorders, Reprod. Toxicol, vol.68, pp.3-33, 2016. ,
Methodology for the validation of isotopic analyses by mass spectrometry in stable-isotope labeling experiments, Anal. Chem, vol.90, pp.1852-1860, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01886456